Previous work has shown that NOS2-derived NO and COX2-derived PGE2 collaborate in a feedforward manner to activate multiple oncogenic pathways that promote metastasis, cancer stemness, and immunosuppression, which are all markers of disease progression (2, 38). Here, NOS2 is linked to cancer.